Chemoinformaics analysis of (-)-Epi-beta-bisabolol
| Molecular Weight | 222.372 | nRot | 4 |
| Heavy Atom Molecular Weight | 196.164 | nRig | 7 |
| Exact Molecular Weight | 222.198 | nRing | 1 |
| Solubility: LogS | -4.635 | nHRing | 0 |
| Solubility: LogP | 5.199 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 42 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 43.1886 |
| nHD | 1 | BPOL | 26.0834 |
| QED | 0.706 |
| Synth | 4.042 |
| Natural Product Likeliness | 3.205 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.575 |
| Pgp-sub | 0.003 |
| HIA | 0.006 |
| CACO-2 | -4.422 |
| MDCK | 0.0000161 |
| BBB | 0.269 |
| PPB | 0.938318 |
| VDSS | 4.331 |
| FU | 0.0547535 |
| CYP1A2-inh | 0.779 |
| CYP1A2-sub | 0.153 |
| CYP2c19-inh | 0.376 |
| CYP2c19-sub | 0.699 |
| CYP2c9-inh | 0.212 |
| CYP2c9-sub | 0.743 |
| CYP2d6-inh | 0.084 |
| CYP2d6-sub | 0.097 |
| CYP3a4-inh | 0.271 |
| CYP3a4-sub | 0.212 |
| CL | 13.021 |
| T12 | 0.158 |
| hERG | 0.028 |
| Ames | 0.003 |
| ROA | 0.007 |
| SkinSen | 0.955 |
| Carcinogencity | 0.385 |
| EI | 0.969 |
| Respiratory | 0.025 |
| NR-Aromatase | 0.024 |
| Antiviral | Yes |
| Prediction | 0.792025 |